The content on this site is intended for healthcare professionals only
Dr Henschke presents at the Future Horizons in Lung Cancer meeting about how we can avoid false positives in lung cancer screening.
New classification for identifying HR myeloma based on cytogenetic abnormalities
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Cancer mutation prediction using artificial intelligence
Best practice in HRRm testing in patients with metastatic prostate cancer
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients
A reproducibility study in pulmonary adenocarcinomas supports a revised classification
Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA
